Title
Negating Fundamentalism: Ibsen's Brand in Bangladesh,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Bangladesh's leading theatre group, Centre for Asian Theatre premired Ibsen's Brand in 2004. It was produced at a time when Bangladesh caught the attention of the world for the rise of Islamic fundamentalist elements across the country. The sociopolitical events of the country let the audience associate Brand, a Christian fanatic, with his Muslim counterparts in Bangladesh.The spectators could relate the performance to their time and setting although,in stark contrast to the conventional Ibsen theatre practices, no attempts were made in it to customise Ibsen to make him relevant to contemporary Bangladesh. That the spectators could appreciate it even when it remained "true" to the original, the present work argues, reveals that a "foreign" play is perceived and understood in local perspectives.It analyses the performance and relates it to the militant activities in Bangladesh in the recent past to argue that the performance is an indictment of fundamentalism in Bangladesh. As such,it will be useful for those interested in theatre and performance analysis as well as in the history and politics of Bangladesh.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.